连续血糖监测联合家庭行为干预对幼儿1型糖尿病血糖及家长生活质量的影响:随机临床试验
该多中心随机对照试验纳入143例2至<8岁1型糖尿病患儿,比较CGM联合家庭行为干预(CGM+FBI)、单用CGM(Standard-CGM)与指尖血糖监测(BGM)对血糖结局及家长生活质量的影响。6个月时CGM组约90%参与者每周使用CGM≥6天;组间TIR(70-180 mg/dL)无显著变化,但CGM+FBI和Standard-CGM组低血糖时间(<70 mg/dL)较BGM显著减少,且CGM+FBI组家长糖尿病负担和低血糖恐惧改善更明显。
要点
- 幼儿1型糖尿病持续使用CGM6个月未改善TIR,但显著减少低血糖时间。
- CGM联合家庭行为干预可改善家长糖尿病负担和低血糖恐惧。
- CGM+FBI组无严重低血糖事件,BGM组发生5例。
核心结论
- 在2至<8岁1型糖尿病患儿中持续使用CGM6个月未显著改善TIR,但显著减少低血糖时间。
- 家庭行为干预(FBI)对家长心理健康有益。
研究设计与样本
- 多中心(N=14)、6个月随机对照试验,纳入143例2至<8岁1型糖尿病患儿。
- 比较CGM+FBI、Standard-CGM与BGM三组,主要分析为随访期间TIR(70-180 mg/dL)的组间比较。
主要发现
- 6个月时CGM组约90%参与者每周使用CGM≥6天。
- 组间TIR变化无显著差异:CGM+FBI vs BGM 3.2%(95%CI -0.5, 7.0),Standard-CGM vs BGM 0.5%(-2.6至3.6),CGM+FBI vs Standard-CGM 2.7%(-0.6, 6.1)。
- 低血糖时间(<70 mg/dL)从基线至随访:CGM+FBI组5.2%降至2.6%,Standard-CGM组5.8%降至2.5%,BGM组5.4%升至5.8%(CGM+FBI vs BGM P<0.001;Standard-CGM vs BGM P<0.001)。
- 严重低血糖事件:CGM+FBI组0例,Standard-CGM组1例,BGM组5例。
- CGM+FBI组家长糖尿病负担和低血糖恐惧的改善优于Standard-CGM(P=0.008和0.04)和BGM(P=0.02和0.002)。
临床怎么用
- 对于2至<8岁1型糖尿病患儿,可考虑使用CGM以减少低血糖时间,即使TIR未显著改善。
- 联合家庭行为干预可能进一步改善家长的心理负担和低血糖恐惧。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study evaluated the effects of continuous glucose monitoring (CGM) combined with family behavioral intervention (CGM+FBI) and CGM alone (Standard-CGM) on glycemic outcomes and parental quality of life compared with blood glucose monitoring (BGM) in children ages 2 to <8 years with type 1 diabetes. RESEARCH DESIGN AND METHODS: This was a multicenter (N = 14), 6-month, randomized controlled trial including 143 youth 2 to <8 years of age with type 1 diabetes. Primary analysis included treatment group comparisons of percent time in range (TIR) (70-180 mg/dL) across follow-up visits. RESULTS: Approximately 90% of participants in the CGM groups used CGM ≥6 days/week at 6 months. Between-group TIR comparisons showed no significant changes: CGM+FBI vs. BGM 3.2% (95% CI -0.5, 7.0), Standard-CGM vs. BGM 0.5% (-2.6 to 3.6), CGM+FBI vs. Standard-CGM 2.7% (-0.6, 6.1). Mean time with glucose level <70 mg/dL was reduced from baseline to follow-up in the CGM+FBI (from 5.2% to 2.6%) and Standard-CGM (5.8% to 2.5%) groups, compared with 5.4% to 5.8% with BGM (CGM+FBI vs. BGM, P < 0.001, and Standard-CGM vs. BGM, P < 0.001). No severe hypoglycemic events occurred in the CGM+FBI group, one occurred in the Standard-CGM group, and five occurred in the BGM group. CGM+FBI parents reported greater reductions in diabetes burden and fear of hypoglycemia compared with Standard-CGM (P = 0.008 and 0.04) and BGM (P = 0.02 and 0.002). CONCLUSIONS: CGM used consistently over a 6-month period in young children with type 1 diabetes did not improve TIR but did significantly reduce time in hypoglycemia. The FBI benefited parental well-being.
引用
- A Randomized Clinical Trial Assessing Continuous Glucose Monitoring (CGM) Use With Standardized Education With or Without a Family Behavioral Intervention Compared With Fingerstick Blood Glucose Monitoring in Very Young Children With Type 1 Diabetes. Diabetes Care. 2020. PMID: 33334807. doi:10.2337/dc20-1060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。